INO – Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

INO

$1.92

Name : Inovio Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $70,413,120.00

EPSttm : -3.95

Inovio Pharmaceuticals, Inc.

$1.92

1.03%

$0.02

Float Short %

17.75

Margin Of Safety %

Put/Call OI Ratio

0.02

EPS Next Q Diff

0.01

EPS Last/This Y

1.34

EPS This/Next Y

0.27

Price

1.92

Target Price

7.83

Analyst Recom

Performance Q

1.05

Relative Volume

0.89

Beta

1.35

Ticker: INO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	INO	1.765	0.03	0.00	13226
2025-04-15	INO	1.75	0.03	0.00	13252
2025-04-16	INO	1.73	0.03	0.00	13206
2025-04-17	INO	1.746	0.03	0.00	13204
2025-04-18	INO	1.74	0.03	0.00	13204
2025-04-21	INO	1.785	0.03	0.19	12451
2025-04-22	INO	1.84	0.03	17.33	12572
2025-04-23	INO	1.86	0.04	0.00	12624
2025-04-24	INO	1.915	0.04	0.00	12625
2025-04-25	INO	1.87	0.037632653061224	1.1538461538462	12711
2025-04-28	INO	1.89	0.027764046795189	0.076923076923077	12475
2025-04-29	INO	1.9	0.03	0.02	12472
2025-04-30	INO	1.94	0.03	0.02	12874
2025-05-01	INO	1.885	0.03	0.00	12885
2025-05-02	INO	1.915	0.02	0.16	16808
2025-05-05	INO	1.85	0.02	0.00	16743
2025-05-06	INO	1.71	0.02	0.01	16755
2025-05-07	INO	1.755	0.02	0.00	17360
2025-05-08	INO	1.815	0.02	3.20	17377
2025-05-09	INO	1.8	0.04	0.18	17683
2025-05-12	INO	1.935	0.02	0.01	17391
2025-05-13	INO	1.92	0.02	0.03	17498
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	INO	1.77	43.5	-	-2.61
2025-04-15	INO	1.76	43.5	-	-2.61
2025-04-16	INO	1.73	43.5	-	-2.61
2025-04-17	INO	1.74	43.5	-	-2.61
2025-04-18	INO	1.74	43.5	-	-2.61
2025-04-21	INO	1.78	43.5	-	-2.61
2025-04-22	INO	1.85	43.5	-	-2.61
2025-04-23	INO	1.87	43.5	-	-2.61
2025-04-24	INO	1.92	43.5	-	-2.61
2025-04-25	INO	1.87	43.5	-	-2.61
2025-04-28	INO	1.89	43.5	-	-2.61
2025-04-29	INO	1.91	43.5	-	-2.61
2025-04-30	INO	1.94	43.5	-	-2.61
2025-05-01	INO	1.88	43.5	-	-2.61
2025-05-02	INO	1.92	43.5	-	-2.61
2025-05-05	INO	1.85	43.5	-	-2.61
2025-05-06	INO	1.71	43.5	-	-2.61
2025-05-07	INO	1.76	43.5	-	-2.61
2025-05-08	INO	1.81	43.5	-	-2.61
2025-05-09	INO	1.80	43.5	-	-2.61
2025-05-12	INO	1.94	43.5	-	-2.61
2025-05-13	INO	1.92	43.5	-	-2.61
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	INO	0.00	84.49	17.57
2025-04-15	INO	0.00	84.49	17.57
2025-04-16	INO	0.00	84.49	17.57
2025-04-17	INO	0.00	84.49	17.57
2025-04-18	INO	0.00	84.49	17.57
2025-04-21	INO	0.00	83.39	17.57
2025-04-22	INO	0.00	83.39	17.57
2025-04-23	INO	0.00	83.39	17.57
2025-04-24	INO	0.00	83.39	17.57
2025-04-25	INO	0.00	83.39	17.57
2025-04-28	INO	0.00	90.08	18.34
2025-04-29	INO	0.00	90.08	18.34
2025-04-30	INO	0.00	90.08	18.34
2025-05-01	INO	0.00	90.08	18.34
2025-05-02	INO	0.00	90.08	18.34
2025-05-05	INO	0.00	77.19	18.34
2025-05-06	INO	0.00	77.19	18.34
2025-05-07	INO	0.00	77.19	18.34
2025-05-08	INO	0.00	77.19	18.34
2025-05-09	INO	0.00	77.19	18.34
2025-05-12	INO	0.00	62.16	17.75
2025-05-13	INO	0.00	62.16	17.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.69

Avg. EPS Est. Current Quarter

-0.74

Avg. EPS Est. Next Quarter

-0.68

Insider Transactions

Institutional Transactions

62.16

Beta

1.35

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.5

Max Drawdown 5-Year %

-99.6

Target Price

7.83

P/E

Forward P/E

PEG

P/S

320.07

P/B

1.01

P/Free Cash Flow

EPS

-3.98

Average EPS Est. Cur. Y

-2.61

EPS Next Y. (Est.)

-2.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-49254.27

Relative Volume

0.89

Return on Equity vs Sector %

-180.3

Return on Equity vs Industry %

-163.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.48

EBIT Estimation

Inovio Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 134

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

stock quote shares INO – Inovio Pharmaceuticals, Inc. Stock Price stock today

news today INO – Inovio Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch INO – Inovio Pharmaceuticals, Inc. yahoo finance google finance

stock history INO – Inovio Pharmaceuticals, Inc. invest stock market

stock prices INO premarket after hours

ticker INO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

INO – Inovio Pharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: INO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y